- Home
- PARK vs DXR Comparison
PARK vs DXR Comparison
Compare PARK & DXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
N/A
Current Price
$14.01
HOLD
Current Price
$12.50
Company Overview
Basic Information| Metric | PARK | DXR |
|---|---|---|
| Founded | 1972 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 67.5M | 66.3M |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | PARK | DXR |
|---|---|---|
| Price | $14.01 | $12.50 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $25.00 |
| AVG Volume (30 Days) | ★ 156.9K | 4.3K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 3.18 | ★ 3.46 |
| EPS | ★ 2.91 | 0.36 |
| Revenue | ★ $240,209,000.00 | $66,306.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ $5.43 | $34.66 |
| Revenue Growth | ★ 7.47 | N/A |
| 52 Week Low | $9.53 | $6.55 |
| 52 Week High | $17.84 | $14.15 |
Technical Indicators
Market Signals| Indicator | PARK | DXR |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 43.47 |
| Support Level | N/A | $12.21 |
| Resistance Level | N/A | $13.02 |
| Average True Range (ATR) | 0.00 | 0.49 |
| MACD | 0.00 | -0.06 |
| Stochastic Oscillator | 0.00 | 19.02 |
Price Performance
Historical Comparison PARK
DXR
About DXR Daxor Corporation
Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA to provide safe, accurate, objective quantification of blood volume status and composition compared to patient-specific norms in a broad range of medical conditions.